Zacks: Oxford Biomedica (OXBDF) Given Average Rating of “Strong Buy” by Analysts
Oxford Biomedica (NASDAQ:OXBDF) has earned an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating.
Zacks has also given Oxford Biomedica an industry rank of 167 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research cut Oxford Biomedica from a “hold” rating to a “sell” rating in a report on Tuesday, April 4th.
ILLEGAL ACTIVITY NOTICE: This story was published by American Banking News and is the sole property of of American Banking News. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/06/14/zacks-oxford-biomedica-oxbdf-given-average-rating-of-strong-buy-by-analysts.html.
Oxford Biomedica (NASDAQ:OXBDF) traded up 0.0000% during trading on Wednesday, reaching $0.0613. The firm’s market capitalization is $189.05 million. Oxford Biomedica has a 12-month low of $0.04 and a 12-month high of $0.09.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.